Overcoming tumor multidrug resistance using drugs able to evade P‐glycoprotein or to exploit its expression

Iwao Ojima, John C. Slater, Evelyne Michaud, Scott D. Kuduk, Pierre-Yves Bounaud, Patricia Vrignaud, Marie-Christine Bissery, Jean M. Veith, Paula Pera, Ralph J. Bernacki, Syntheses and structure-activity relationships of the second-generation antitumor taxoids: exceptional activity against drug-resistant cancer cells. Journal of Medicinal Chemistry. ,vol. 39, pp. 3889- 3896 ,(1996) , 10.1021/JM9604080

J Guo, M G Anderson, P Tapang, J P Palma, L E Rodriguez, A Niquette, J Li, J J Bouska, G Wang, D Semizarov, D H Albert, C K Donawho, K B Glaser, O J Shah, Identification of genes that confer tumor cell resistance to the Aurora B kinase inhibitor, AZD1152 Pharmacogenomics Journal. ,vol. 9, pp. 90- 102 ,(2009) , 10.1038/TPJ.2008.20

Diletta Laccabue, Monica Tortoreto, Silvia Veneroni, Paola Perego, Eugenio Scanziani, Massimo Zucchetti, Marco Zaffaroni, Maurizio D'Incalci, Ezio Bombardelli, Franco Zunino, Graziella Pratesi, A novel taxane active against an orthotopically growing human glioma xenograft. Cancer. ,vol. 92, pp. 3085- 3092 ,(2001) , 10.1002/1097-0142(20011215)92:12<3085::AID-CNCR10150>3.0.CO;2-S

Javier Cortes, Linda Vahdat, Joanne L. Blum, Chris Twelves, Mario Campone, Henri Roché, Thomas Bachelot, Ahmad Awada, Robert Paridaens, Anthony Goncalves, Dale E. Shuster, Jantien Wanders, Fang Fang, Renuka Gurnani, Elaine Richmond, Patricia E. Cole, Simon Ashworth, Mary Ann Allison, Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine Journal of Clinical Oncology. ,vol. 28, pp. 3922- 3928 ,(2010) , 10.1200/JCO.2009.25.8467

Alex Sparreboom, Hans Gelderblom, Sharon Marsh, Ranjeet Ahluwalia, Rosendo Obach, Paola Principe, Chris Twelves, Jaap Verweij, Howard L McLeod, Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype Clinical Pharmacology & Therapeutics. ,vol. 76, pp. 38- 44 ,(2004) , 10.1016/J.CLPT.2004.03.003

Galina Kuznetsov, Karen TenDyke, Murray J. Towle, Hongsheng Cheng, Junke Liu, Joanne P. Marsh, Shawn E.R. Schiller, Mark R. Spyvee, Hu Yang, Boris M. Seletsky, Christina J. Shaffer, Veronique Marceau, Ye Yao, Edward M. Suh, Silvio Campagna, Francis G. Fang, James J. Kowalczyk, Bruce A. Littlefield, Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin Molecular Cancer Therapeutics. ,vol. 8, pp. 2852- 2860 ,(2009) , 10.1158/1535-7163.MCT-09-0301

François-Xavier Mahon, Francis Belloc, Valérie Lagarde, Claudine Chollet, François Moreau-Gaudry, Josy Reiffers, John M. Goldman, Junia V. Melo, MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models. Blood. ,vol. 101, pp. 2368- 2373 ,(2003) , 10.1182/BLOOD.V101.6.2368

Richard J. Kowalski, Paraskevi Giannakakou, Ernest Hamel, Activities of the Microtubule-stabilizing Agents Epothilones A and B with Purified Tubulin and in Cells Resistant to Paclitaxel (Taxol®) Journal of Biological Chemistry. ,vol. 272, pp. 2534- 2541 ,(1997) , 10.1074/JBC.272.4.2534

Susan L. Mooberry, Tina L. Tinley, Deborah A. Randall-Hlubek, Evelyn M. Jackson, Rachel M. Leal, Thomas K. Hemscheidt, James C. Quada, James W. Cessac, Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity. Cancer Research. ,vol. 63, pp. 3211- 3220 ,(2003)

Tito Fojo, Peter J. Oefner, George E. Duran, Peidong Shen, Branimir I. Sikic, Yan Wang, Kristine Yu, Raphael Sung, Sanja Šale, Jong-Hyeok Kim, Conservation of the Class I -Tubulin Gene in Human Populations and Lack of Mutations in Lung Cancers and Paclitaxel-resistant Ovarian Cancers 1 Molecular Cancer Therapeutics. ,vol. 1, pp. 215- 225 ,(2002)